NM_002386.4:c.652G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_002386.4(MC1R):​c.652G>A​(p.Ala218Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0004 in 1,608,156 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A218G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00028 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00041 ( 1 hom. )

Consequence

MC1R
NM_002386.4 missense

Scores

4
13

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: 2.19

Publications

7 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08498928).
BP6
Variant 16-89919910-G-A is Benign according to our data. Variant chr16-89919910-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 321437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 43 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002386.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MC1R
NM_002386.4
MANE Select
c.652G>Ap.Ala218Thr
missense
Exon 1 of 1NP_002377.4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MC1R
ENST00000555147.2
TSL:6 MANE Select
c.652G>Ap.Ala218Thr
missense
Exon 1 of 1ENSP00000451605.1Q01726
ENSG00000198211
ENST00000556922.1
TSL:2
c.652G>Ap.Ala218Thr
missense
Exon 1 of 5ENSP00000451560.1A0A0B4J269
MC1R
ENST00000555427.1
TSL:5
c.652G>Ap.Ala218Thr
missense
Exon 3 of 4ENSP00000451760.1G3V4F0

Frequencies

GnomAD3 genomes
AF:
0.000283
AC:
43
AN:
152144
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000210
AC:
51
AN:
242354
AF XY:
0.000181
show subpopulations
Gnomad AFR exome
AF:
0.000197
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000347
Gnomad OTH exome
AF:
0.000168
GnomAD4 exome
AF:
0.000412
AC:
600
AN:
1455894
Hom.:
1
Cov.:
35
AF XY:
0.000420
AC XY:
304
AN XY:
724440
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33470
American (AMR)
AF:
0.0000448
AC:
2
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000325
AC:
28
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48072
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5766
European-Non Finnish (NFE)
AF:
0.000485
AC:
539
AN:
1111520
Other (OTH)
AF:
0.000414
AC:
25
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
43
85
128
170
213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000282
AC:
43
AN:
152262
Hom.:
1
Cov.:
33
AF XY:
0.000228
AC XY:
17
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41560
American (AMR)
AF:
0.0000653
AC:
1
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5162
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
68006
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000243
Hom.:
0
Bravo
AF:
0.000268
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000484
AC:
2
ESP6500EA
AF:
0.000358
AC:
3
ExAC
AF:
0.000182
AC:
22
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
Melanoma, cutaneous malignant, susceptibility to, 5 (2)
-
-
1
not provided (1)
-
-
-
Melanoma, cutaneous malignant, susceptibility to, 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.064
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.39
N
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.085
T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
1.8
L
PhyloP100
2.2
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.094
Sift
Uncertain
0.0040
D
Sift4G
Uncertain
0.019
D
Polyphen
0.94
P
Vest4
0.073
MVP
0.50
MPC
0.028
ClinPred
0.021
T
GERP RS
2.9
Varity_R
0.16
gMVP
0.36
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200965363; hg19: chr16-89986318; COSMIC: COSV107321394; COSMIC: COSV107321394; API